Stay updated on Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Sign up to get notified when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.

Latest updates to the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page
- Check5 days agoChange DetectedTel Litwinsky, Israel, 52621 was added as a participating site, replacing Qiryat Krinitzi, Israel, 52621 in the Locations section.SummaryDifference0.0%

- Check12 days agoChange DetectedQiryat Krinitzi, Israel, 52621 was added as a Novo Nordisk investigational site, replacing Tel Litwinsky, Israel, 52621. The page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This indicates a new site release, typically reflecting maintenance updates rather than substantive content changes.SummaryDifference0.0%

- Check47 days agoChange DetectedThe Revision label on the page was updated from v3.6.3 to v3.6.4. This reflects an internal site version update without changes to the study content or user-facing features.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page shows a new revision number, updating from v3.6.2 to v3.6.3, indicating a small backend or UI patch. This change does not affect study content or how users interact with the page.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page, reflecting a minor frontend update to the study details interface.SummaryDifference0.0%

Stay in the know with updates to Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.